Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Dainese

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Epilepsia Open|February 27, 2025
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW)Giorgia Giussani, Elisa Bianchi, Edoardo Carlando, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology|February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal EpilepsyEmanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Seizure|February 9, 2021
Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in ItalyNiccolò Orlandi, Emanuele Bartolini, Daniela Audenino, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Epilepsia Open|February 27, 2025
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW)Giorgia Giussani, Elisa Bianchi, Edoardo Carlando, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology|February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal EpilepsyEmanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Seizure|February 9, 2021
Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in ItalyNiccolò Orlandi, Emanuele Bartolini, Daniela Audenino, et al.
Pageof 4